$VICL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Brickell Biotech, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Brickell Biotech, Inc.. Get notifications about new insider transactions in Brickell Biotech, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Payment of Exercise | F | 1.14 | 5,250 | 5,985 | 11,919 | 17.2 K to 11.9 K (-30.58 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Buy | M | 0.00 | 15,000 | 0 | 17,169 | 2.2 K to 17.2 K (+691.56 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Payment of Exercise | F | 1.14 | 8,750 | 9,975 | 62,967 | 71.7 K to 63 K (-12.20 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Buy | M | 0.00 | 25,000 | 0 | 71,717 | 46.7 K to 71.7 K (+53.51 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Mar 17 2021 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Payment of Exercise | F | 1.14 | 8,750 | 9,975 | 92,133 | 100.9 K to 92.1 K (-8.67 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Buy | M | 0.00 | 25,000 | 0 | 100,883 | 75.9 K to 100.9 K (+32.95 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Payment of Exercise | F | 1.14 | 5,250 | 5,985 | 11,919 | 17.2 K to 11.9 K (-30.58 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Buy | M | 0.00 | 15,000 | 0 | 17,169 | 2.2 K to 17.2 K (+691.56 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Payment of Exercise | F | 1.14 | 8,750 | 9,975 | 62,967 | 71.7 K to 63 K (-12.20 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Payment of Exercise | F | 1.14 | 7,000 | 7,980 | 109,250 | 116.3 K to 109.3 K (-6.02 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Buy | M | 0.00 | 25,000 | 0 | 71,717 | 46.7 K to 71.7 K (+53.51 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Buy | M | 0.00 | 20,000 | 0 | 116,250 | 96.3 K to 116.3 K (+20.78 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Mar 17 2021 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Payment of Exercise | F | 1.14 | 8,750 | 9,975 | 92,133 | 100.9 K to 92.1 K (-8.67 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Buy | M | 0.00 | 25,000 | 0 | 100,883 | 75.9 K to 100.9 K (+32.95 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Payment of Exercise | F | 1.14 | 7,000 | 7,980 | 109,250 | 116.3 K to 109.3 K (-6.02 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Buy | M | 0.00 | 20,000 | 0 | 116,250 | 96.3 K to 116.3 K (+20.78 %) |
| Mar 17 2021 | VICL | Brickell Biotech, ... | Brown Robert Busard | Chief Executive Off ... | Buy | P | 1.18 | 100,000 | 117,780 | 186,957 | 87 K to 187 K (+115.00 %) |
| Sep 21 2020 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Buy | P | 0.84 | 6,000 | 5,039 | 6,000 | 0 to 6 K |
| Sep 21 2020 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Buy | P | 0.83 | 16,526 | 13,713 | 75,883 | 59.4 K to 75.9 K (+27.84 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | A | 0.80 | 60,000 | 48,000 | 60,000 | |
| Sep 17 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Grant | A | 0.81 | 10,493 | 8,499 | 23,542 | 13 K to 23.5 K (+80.41 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | A | 0.80 | 60,000 | 48,000 | 60,000 | |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Gift | G | 0.00 | 19,642 | 0 | 980,030 | 960.4 K to 980 K (+2.05 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | P | 0.80 | 14,645 | 11,758 | 50,810 | 36.2 K to 50.8 K (+40.49 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | P | 0.81 | 15,355 | 12,416 | 36,165 | 20.8 K to 36.2 K (+73.79 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Grant | A | 0.81 | 13,580 | 11,000 | 20,810 | 7.2 K to 20.8 K (+187.83 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Gift | G | 0.00 | 19,642 | 0 | 7,230 | 26.9 K to 7.2 K (-73.09 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | A | 0.80 | 60,000 | 48,000 | 60,000 | |
| Sep 17 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Grant | A | 0.81 | 11,934 | 9,667 | 24,729 | 12.8 K to 24.7 K (+93.27 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | A | 0.80 | 60,000 | 48,000 | 60,000 | |
| Sep 17 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Grant | A | 0.81 | 15,226 | 12,333 | 205,849 | 190.6 K to 205.8 K (+7.99 %) |
| Sep 17 2020 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Option Exercise | A | 0.80 | 350,000 | 280,000 | 350,000 | |
| Sep 16 2020 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Option Exercise | A | 0.80 | 150,000 | 120,000 | 150,000 | |
| Sep 16 2020 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Option Exercise | A | 0.80 | 400,000 | 320,000 | 400,000 | |
| Sep 16 2020 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Option Exercise | A | 0.80 | 450,000 | 360,000 | 450,000 | |
| Sep 16 2020 | VICL | Brickell Biotech, ... | Brown Robert Busard | Chief Executive Off ... | Option Exercise | A | 0.80 | 1,000,000 | 800,000 | 1,000,000 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | M | 0.00 | 788 | 0 | 0 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | M | 0.00 | 788 | 0 | 960,388 | 959.6 K to 960.4 K (+0.08 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | M | 0.00 | 609 | 0 | 0 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 0.94 | 6,375 | 5,993 | 13,049 | 19.4 K to 13 K (-32.82 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 0.94 | 256 | 241 | 19,424 | 19.7 K to 19.4 K (-1.30 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Buy | M | 0.00 | 609 | 0 | 19,680 | 19.1 K to 19.7 K (+3.19 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 0 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 0.94 | 8,631 | 8,113 | 12,795 | 21.4 K to 12.8 K (-40.28 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 0.94 | 346 | 325 | 21,426 | 21.8 K to 21.4 K (-1.59 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 21,772 | 21.1 K to 21.8 K (+3.28 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 883 | 0 | 0 | |
| Sep 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 0.94 | 7,048 | 6,625 | 190,623 | 197.7 K to 190.6 K (-3.57 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 0.94 | 283 | 266 | 197,671 | 198 K to 197.7 K (-0.14 %) |
| Sep 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Buy | M | 0.00 | 883 | 0 | 197,954 | 197.1 K to 198 K (+0.45 %) |
| Aug 04 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 692 | |
| Aug 04 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 0.92 | 346 | 318 | 21,080 | 21.4 K to 21.1 K (-1.61 %) |
| Aug 04 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 21,426 | 20.7 K to 21.4 K (+3.34 %) |
| Aug 04 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 882 | 0 | 883 | |
| Aug 04 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 0.92 | 283 | 260 | 197,071 | 197.4 K to 197.1 K (-0.14 %) |
| Aug 04 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Buy | M | 0.00 | 882 | 0 | 197,354 | 196.5 K to 197.4 K (+0.45 %) |
| Aug 04 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | M | 0.00 | 787 | 0 | 788 | |
| Aug 04 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | M | 0.00 | 787 | 0 | 959,600 | 958.8 K to 959.6 K (+0.08 %) |
| Aug 04 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | M | 0.00 | 608 | 0 | 609 | |
| Aug 04 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 0.92 | 256 | 236 | 19,071 | 19.3 K to 19.1 K (-1.32 %) |
| Aug 04 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Buy | M | 0.00 | 608 | 0 | 19,327 | 18.7 K to 19.3 K (+3.25 %) |
| Jul 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | M | 0.00 | 608 | 0 | 1,217 | |
| Jul 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 1.00 | 256 | 256 | 18,719 | 19 K to 18.7 K (-1.35 %) |
| Jul 02 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Buy | M | 0.00 | 608 | 0 | 18,975 | 18.4 K to 19 K (+3.31 %) |
| Jul 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 691 | 0 | 1,384 | |
| Jul 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.00 | 346 | 346 | 20,734 | 21.1 K to 20.7 K (-1.64 %) |
| Jul 02 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 691 | 0 | 21,080 | 20.4 K to 21.1 K (+3.39 %) |
| Jul 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 883 | 0 | 1,765 | |
| Jul 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 1.00 | 283 | 283 | 196,472 | 196.8 K to 196.5 K (-0.14 %) |
| Jul 02 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Buy | M | 0.00 | 883 | 0 | 196,755 | 195.9 K to 196.8 K (+0.45 %) |
| Jul 02 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | M | 0.00 | 787 | 0 | 1,575 | |
| Jul 02 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | M | 0.00 | 787 | 0 | 958,813 | 958 K to 958.8 K (+0.08 %) |
| Jun 22 2020 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Option Exercise | P | 1.25 | 13,044 | 16,305 | 13,044 | |
| Jun 22 2020 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Buy | P | 0.00 | 13,044 | 0 | 96,250 | 83.2 K to 96.3 K (+15.68 %) |
| Jun 22 2020 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Option Exercise | P | 1.25 | 30,435 | 38,044 | 30,435 | |
| Jun 22 2020 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Buy | P | 0.00 | 30,435 | 0 | 59,357 | 28.9 K to 59.4 K (+105.23 %) |
| Jun 22 2020 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Option Exercise | P | 1.25 | 26,087 | 32,609 | 26,087 | |
| Jun 22 2020 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Buy | P | 0.00 | 26,087 | 0 | 46,717 | 20.6 K to 46.7 K (+126.45 %) |
| Jun 22 2020 | VICL | Brickell Biotech, ... | Brown Robert Busard | Chief Executive Off ... | Option Exercise | P | 1.25 | 86,957 | 108,696 | 86,957 | |
| Jun 22 2020 | VICL | Brickell Biotech, ... | Brown Robert Busard | Chief Executive Off ... | Buy | P | 0.00 | 86,957 | 0 | 86,957 | 0 to 87 K |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | A | 1.12 | 4,333 | 4,853 | 4,333 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | M | 0.00 | 787 | 0 | 787 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | M | 0.00 | 787 | 0 | 787 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | M | 0.00 | 787 | 0 | 787 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | M | 0.00 | 787 | 0 | 787 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Option Exercise | M | 0.00 | 3,973 | 0 | 3,973 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Grant | A | 0.00 | 19,642 | 0 | 26,872 | 7.2 K to 26.9 K (+271.67 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | M | 0.00 | 787 | 0 | 958,026 | 957.2 K to 958 K (+0.08 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | M | 0.00 | 787 | 0 | 957,239 | 956.5 K to 957.2 K (+0.08 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | M | 0.00 | 787 | 0 | 956,452 | 955.7 K to 956.5 K (+0.08 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | M | 0.00 | 787 | 0 | 955,665 | 954.9 K to 955.7 K (+0.08 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | VERU DENNISON T | Director | Buy | M | 0.00 | 3,973 | 0 | 954,878 | 950.9 K to 954.9 K (+0.42 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | A | 1.12 | 4,333 | 4,853 | 4,333 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | M | 0.00 | 608 | 0 | 608 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | M | 0.00 | 609 | 0 | 609 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | M | 0.00 | 608 | 0 | 608 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | M | 0.00 | 608 | 0 | 608 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Option Exercise | M | 0.00 | 3,070 | 0 | 3,070 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Grant | A | 0.00 | 15,178 | 0 | 18,367 | 3.2 K to 18.4 K (+475.95 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 1.16 | 256 | 297 | 3,189 | 3.4 K to 3.2 K (-7.43 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Buy | M | 0.00 | 608 | 0 | 3,445 | 2.8 K to 3.4 K (+21.43 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 1.20 | 256 | 307 | 2,837 | 3.1 K to 2.8 K (-8.28 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Buy | M | 0.00 | 609 | 0 | 3,093 | 2.5 K to 3.1 K (+24.52 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 1.19 | 256 | 305 | 2,484 | 2.7 K to 2.5 K (-9.34 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Buy | M | 0.00 | 608 | 0 | 2,740 | 2.1 K to 2.7 K (+28.52 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 2.93 | 256 | 750 | 2,132 | 2.4 K to 2.1 K (-10.72 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Buy | M | 0.00 | 608 | 0 | 2,388 | 1.8 K to 2.4 K (+34.16 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Payment of Exercise | F | 1.16 | 1,290 | 1,496 | 1,780 | 3.1 K to 1.8 K (-42.02 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | SAMANT VIJAY B | Director | Buy | M | 0.00 | 3,070 | 0 | 3,070 | 0 to 3.1 K |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | A | 1.12 | 4,333 | 4,853 | 4,333 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 692 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 692 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 691 | 0 | 691 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 692 | 0 | 692 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 3,491 | 0 | 3,491 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Grant | A | 0.00 | 17,261 | 0 | 20,389 | 3.1 K to 20.4 K (+551.82 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.16 | 346 | 401 | 3,128 | 3.5 K to 3.1 K (-9.96 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 3,474 | 2.8 K to 3.5 K (+24.87 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.20 | 346 | 415 | 2,782 | 3.1 K to 2.8 K (-11.06 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 3,128 | 2.4 K to 3.1 K (+28.41 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.19 | 346 | 412 | 2,436 | 2.8 K to 2.4 K (-12.44 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 691 | 0 | 2,782 | 2.1 K to 2.8 K (+33.05 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 2.93 | 346 | 1,014 | 2,091 | 2.4 K to 2.1 K (-14.20 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 692 | 0 | 2,437 | 1.7 K to 2.4 K (+39.66 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Payment of Exercise | F | 1.16 | 1,746 | 2,025 | 1,745 | 3.5 K to 1.7 K (-50.01 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | LYONS GARY A | Director | Buy | M | 0.00 | 3,491 | 0 | 3,491 | 0 to 3.5 K |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | A | 1.12 | 5,333 | 5,973 | 5,333 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 882 | 0 | 882 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 883 | 0 | 883 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 882 | 0 | 882 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 883 | 0 | 883 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 4,454 | 0 | 4,454 | |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Grant | A | 0.00 | 22,023 | 0 | 195,872 | 173.8 K to 195.9 K (+12.67 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 1.16 | 283 | 328 | 173,849 | 174.1 K to 173.8 K (-0.16 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Buy | M | 0.00 | 882 | 0 | 174,132 | 173.3 K to 174.1 K (+0.51 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 1.20 | 283 | 340 | 173,250 | 173.5 K to 173.3 K (-0.16 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Buy | M | 0.00 | 883 | 0 | 173,533 | 172.7 K to 173.5 K (+0.51 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 1.19 | 283 | 337 | 172,650 | 172.9 K to 172.7 K (-0.16 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Buy | M | 0.00 | 882 | 0 | 172,933 | 172.1 K to 172.9 K (+0.51 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 2.93 | 283 | 829 | 172,051 | 172.3 K to 172.1 K (-0.16 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Buy | M | 0.00 | 883 | 0 | 172,334 | 171.5 K to 172.3 K (+0.52 %) |
| Jun 05 2020 | VICL | Brickell Biotech, ... | HARDY REGINALD L | Chairman of the Boa ... | Payment of Exercise | F | 1.16 | 1,426 | 1,654 | 171,451 | 172.9 K to 171.5 K (-0.82 %) |